References
- Australian Institute of Health and Welfare (AIHW). Allergic rhinitis (‘hay fever’); 2019. Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/allergic-rhinitis-hay-fever/contents/allergic-rhinitis. Accessed May 1, 2022.
- Australasian Society of Clinical Immunology and Allergy (ASCIA). Allergic rhinitis clinical update; 2020.
- Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol. 2001;108(1):S45–S53. doi:10.1067/mai.2001.115566
- Speth MM, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Treatment history and association between allergic rhinitis symptoms and quality of life. Ir J Med Sci. 2019;188(2):703–710. doi:10.1007/s11845-018-1866-2
- Camelo-Nunes IC, Solé D. Allergic rhinitis: indicators of quality of life. J Bras Pneumol. 2010;36:124–133. doi:10.1590/S1806-37132010000100017
- National Asthma Council Australia (NACA). Allergic rhinitis treatments chart; 2021. Available from: https://www.nationalasthma.org.au/living-with-asthma/resources/health-professionals/charts/allergic-rhinitis-treatments-chart. Accessed November 15, 2022.
- Meltzer EO, Stahlman JE, Leflein J, et al. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study. Clin Ther. 2008;30(2):271–279. doi:10.1016/j.clinthera.2008.02.005
- Meltzer EO, Bardelas J, Goldsobel A, Kaiser H. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis. Treat Respir Med. 2005;4(4):289–296. doi:10.2165/00151829-200504040-00007
- Mahadevia PJ, Shah S, Leibman C, Kleinman L, O’Dowd L. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Ann Allergy Asthma Immunol. 2004;93(4):345–350. doi:10.1016/S1081-1206(10)61393-2
- Meltzer EO, Garadi R, LaForce C, et al. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%. In: Allergy and Asthma Proceedings. Vol. 29. OceanSide Publications, Inc; 2008:659–668.
- Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Policy Mark. 1992;11(2):12–25. doi:10.1177/074391569201100202
- Louviere JJ, Woodworth GG. Best-worst scaling: a model for the largest difference judgments. Faculty of Business. University of Sydney; 1990.
- Lancsar E, Louviere J, Donaldson C, Currie G, Burgess L. Best worst discrete choice experiments in health: methods and an application. Soc Sci Med. 2013;76:74–82. doi:10.1016/j.socscimed.2012.10.007
- Mühlbacher AC, Kaczynski A, Zweifel P, Johnson FR. Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview. Health Econ Rev. 2016;6(1):1–14. doi:10.1186/s13561-016-0080-z
- Burke PF, Rose JM, Fifer S, Masters D, Kuegler S, Cabrera A. A new subjective well-being index using anchored best-worst scaling; 2022. Social Science Research. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4322054. Accessed January 13, 2023.
- Forsta. Forsta plus survey platform; 2022. Available from: https://www.forsta.com/platform/survey-design/. Accessed November 15, 2022.
- Meltzer EO, Hadley J, Blaiss M, et al. Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitis. Otolaryngology. 2005;132(2):197–207. doi:10.1016/j.otohns.2004.10.010
- Australian Institute of Health and Welfare (AIHW). Allergic rhinitis (‘hay fever’); 2020. Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/allergic-rhinitis-hay-fever. Accessed May 1, 2022.
- Australian Institute of Health and Welfare (AIHW). Allergic rhinitis (‘hay fever’) in Australia; 2011. Available from: https://www.aihw.gov.au/getmedia/f155276c-b1c1-4bb9-94de-e7e09555bce4/13567.pdf.aspx?inline=true. Accessed May 1, 2022.